pentagastrin has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebeid, AM; Escourrou, J; Fischer, JE; Murray, P; Soeters, PB | 1 |
| Dubrasquet, M; Gislon, J | 1 |
1 review(s) available for pentagastrin and Liver Dysfunction
| Article | Year |
|---|---|
[Portal system and gastric hypersecretion. Pathophysiologic hypotheses].
Topics: Animals; Dogs; Gastric Juice; Gastric Mucosa; Gastrins; Humans; Intestine, Small; Liver; Liver Diseases; Pancreas; Pancreatic Diseases; Pentagastrin; Portal System; Rats; Secretory Rate | 1974 |
1 other study(ies) available for pentagastrin and Liver Dysfunction
| Article | Year |
|---|---|
Hepatic inactivation of vasoactive intestinal peptide in man and dog.
Topics: Animals; Antigens; Calcium; Dogs; Gastrointestinal Hormones; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Neostigmine; Pentagastrin; Portacaval Shunt, Surgical; Portal Vein; Stimulation, Chemical; Vasoactive Intestinal Peptide; Veins | 1978 |